Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Bachmeier, Beatrice E ^a   Iancu, Cristina M ^a,b   Killian, Peter H ^a   Kronski, Emanuel ^a   Mirisola, Valentina ^d   Angelini, Giovanna ^d   Jochum, Marianne ^a   Nerlich, Andreas G ^c   Pfeffer, Ulrich ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CURCUMIN; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; ABC TRANSPORTER; ANTINEOPLASTIC AGENT; PRIMER DNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; DRUG RESISTANCE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

MUS MUSCULUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CURCUMIN; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA;

EID: 74549217174     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-129     Document Type: Article

References (48)

1. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991, 57:1-7. 10.1055/s-2006-960004, 2062949.
2. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. JAmCollNutr 1992, 11:192-198.
3. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vene R, Dell'Eva R, Jochum M, Albini A, Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 2007, 19:137-152. 10.1159/000099202, 17310108.
4. Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Hohneke C, Jochum M, Nerlich AG, Pfeffer U. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 2008, 29:779-789. 10.1093/carcin/bgm248, 17999991.
5. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003, 65:250-258. 10.1159/000074478, 14657599.
6. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008, 269:199-225. 10.1016/j.canlet.2008.03.009, 18479807.
7. Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 1999, 19:3675-3680.
8. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H, Ho CT. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 1998, 19:1697-1700. 10.1093/carcin/19.9.1697, 9771944.
9. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 1997, 116:197-203. 10.1016/S0304-3835(97)00187-0, 9215864.
10. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999, 59:597-601.
11. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000, 21:331-335. 10.1093/carcin/21.2.331, 10657978.
12. Kesmodel SB, Spitz FR. Gene therapy for cancer and metastatic disease. Expert Rev Mol Med 2003, 5:1-18. 10.1017/S1462399403006380, 14585164.
13. Marin YE, Wall BA, Wang S, Namkoong J, Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, Ryu JH. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res 2007, 17:274-283. 10.1097/CMR.0b013e3282ed3d0e, 17885582.
14. Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 2005, 104:879-890. 10.1002/cncr.21216, 16007726.
15. Westphal JR, Van't Hullenaar R, Peek R, Willems RW, Crickard K, Crickard U, Askaa J, Clemmensen I, Ruiter DJ, De Waal RM. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer 2000, 86:768-776. 10.1002/(SICI)1097-0215(20000615)86:6<768::AID-IJC3>3.0.CO;2-E, 10842189.
16. Westphal JR, van't Hullenaar RG, Laak JA, Cornelissen IM, Schalkwijk LJ, van Muijen GN, Wesseling P, de Wilde PC, Ruiter DJ, de Waal RM. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer 1997, 76:561-570. 2228011, 9303353.
17. Thies A, Mauer S, Fodstad O, Schumacher U. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. Br J Cancer 2007, 96:609-616. 10.1038/sj.bjc.6603594, 2360047, 17262079.
18. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003, 101:1053-1062. 10.1182/blood-2002-05-1320, 12393461.
19. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 2004, 101:2351-2362. 10.1002/cncr.20605, 15476283.
20. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. JBiolChem 1995, 270:24995-25000.
21. Vermeulen L, De Wilde G, Notebaert S, Berghe W, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. BiochemPharmacol 2002, 64:963-970.
22. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends BiochemSci 2005, 30:43-52.
23. Wang CY, Mayo MW, Baldwin AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787. 10.1126/science.274.5288.784, 8864119.
24. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784. 10.1126/science.274.5288.782, 8864118.
25. Garg A, Aggarwal BB. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002, 16:1053-1068. 10.1038/sj.leu.2402482, 12040437.
26. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524. 10.1038/nature03799, 1283098, 16049480.
27. Dhawan P, Richmond A. Role of CXCL1 in tumorigenesis of melanoma. JLeukocBiol 2002, 72:9-18.
28. Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006, 86:849-899. 10.1152/physrev.00035.2005, 16816140.
29. Netzker R, Weigert C, Brand K. Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. EurJBiochem 1997, 245:174-181.
30. Bachmeier BE, Nerlich AG. Immunohistochemical pattern of cytokeratins and MMPs in human keratinocyte cell lines of different biological behaviour. IntJOncol 2002, 20:495-499.
31. Bachmeier BE, Nerlich AG, Lichtinghagen R, Sommerhoff CP. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 2001, 21:3821-3828.
32. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods MolBiol 2000, 132:365-386.
33. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002, 32:1372-1379.
34. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. ProcNatlAcadSciUSA 2001, 98:5116-5121.
35. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008, 1:13. 10.1186/1755-8794-1-13, 2408576, 18442402.
36. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54. 10.1038/ng1060, 12469122.
37. Albini A, Mirisola V, Pfeffer U. Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev 2008, 27:75-83. 10.1007/s10555-007-9111-x, 18046511.
38. Haghnegahdar H, Du J, Wang D, Strieter RM, Burdick MD, Nanney LB, Cardwell N, Luan J, Shattuck-Brandt R, Richmond A. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 2000, 67:53-62. 2669312, 10647998.
39. Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V, Mauch C, Dragulev B, Fox JW. Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 2005, 65:4134-4146. 10.1158/0008-5472.CAN-04-0415, 15899804.
40. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 2008, 259:111-118. 10.1016/j.canlet.2007.10.003, 18006147.
41. Wahl H, Tan L, Griffith K, Choi M, Liu JR. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. GynecolOncol 2007, 105:104-112.
42. Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. AntioxidRedoxSignal 2005, 7:1630-1647.
43. Kamat AM, Sethi G, Aggarwal BB. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. MolCancer Ther 2007, 6:1022-1030.
44. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999, 22:347-351. 10.1038/11914, 10431237.
45. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345. 10.1038/11905, 10431236.
46. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 1991, 14:839-855. 10.2337/diacare.14.9.839, 1959476.
47. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005, 12:295-300.
48. Berrino F, Villarini A, De Petris M, Raimondi M, Pasanisi P. Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci 2006, 1089:110-118. 10.1196/annals.1386.023, 17261760.